Letters to the Editor

Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy

Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital
Radiology Department, Austin Health Heidelberg; Department of Molecular Imaging and Therapy, Austin Health
Department of Molecular Imaging and Therapy, Austin Health
Clinical Haematology, Austin Health
Radiology Department, Austin Health Heidelberg; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg; Department of Medicine, University of Melbourne
Department of Endocrinology and Diabetes, Alfred Health, Melbourne; Department of Medicine, Monash University, Melbourne
Department of Medicine, University of Melbourne, Melbourne; Department of Endocrinology, Austin Health
Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital
Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital, Heidelberg; Department of Medicine, University of Melbourne, Melbourne; Department of Medical Oncology, Austin Hospital
Clinical Haematology, Austin Health, Heidelberg; Clinical Haematology, Monash Health, Clayton
Clinical Haematology, Austin Health, Heidelberg; Lymphoma Clinical Innovations Group, Olivia Newton John Cancer and Research Institute, Austin Hospital, Heidelberg; Department of Medicine, University of Melbourne, Melbourne; Department of Medical Oncology, Austin Hospital, Heidelberg; School of Public Health and Preventative Medicine, Monash University
Haematologica Early view Jan 23, 2025 https://doi.org/10.3324/haematol.2024.286618